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Abstract
 
Leukotrienes are derived from arachidonic acid and serve as mediators of inflammation and im-
 
mediate hypersensitivity. Leukotriene B
 
4
 
 (LTB
 
4
 
) and leukotriene C
 
4
 
 (LTC
 
4
 
) act through G pro-
tein–coupled receptors LTB
 
4
 
 receptor (BLTR) and Cys-LTR, respectively. To investigate the
physiological role of BLTR, we produced mice with a targeted disruption of the BLTR gene.
 
Mice deficient for BLTR (BLTR
 
2
 
/
 
2
 
) developed normally and had no apparent hematopoietic
abnormalities. Peritoneal neutrophils from BLTR
 
2
 
/
 
2
 
 mice displayed normal responses to the
inflammatory mediators C5a and platelet-activating factor (PAF) but did not respond to LTB
 
4
 
for calcium mobilization or chemotaxis. Additionally, LTB
 
4
 
 elicited peritoneal neutrophil in-
flux in control but not in BLTR
 
2
 
/
 
2
 
 mice. Thus, BLTR is the sole receptor for LTB
 
4
 
-induced
inflammation in mice. Neutrophil influx in a peritonitis model and acute ear inflammation in
response to arachidonic acid was significantly reduced in BLTR
 
2
 
/
 
2
 
 mice. In mice, intravenous
administration of PAF induces immediate lethal anaphylaxis. Surprisingly, female BLTR
 
2
 
/
 
2
 
mice displayed selective survival (6 of 9;
 
 P 
 
5 
 
0.002) relative to male (1 of 11) mice of PAF-
induced anaphylaxis. These results demonstrate the role of BLTR in leukotriene-mediated
acute inflammation and an unexpected sex-related involvement in PAF-induced anaphylaxis.
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Introduction
 
Leukotriene B
 
4
 
 (LTB
 
4
 
) is a potent chemoattractant for neu-
trophils, eosinophils, and macrophages and also activates
the respiratory burst and granule release from neutrophils
(1). Leukotriene C
 
4
 
 (LTC
 
4
 
) activates smooth muscles and is
a potent bronchoconstrictor (2, 3). G protein–coupled re-
ceptors LTB
 
4
 
 receptor (BLTR) and Cys-LTR mediate the
activity of LTB
 
4
 
 and LTC
 
4
 
, respectively (4, 5). BLTR is
expressed in spleen and on leukocytes, whereas Cys-LTR
is expressed mainly in smooth muscle and spleen and on
leukocytes and pulmonary macrophages. BLTRs activate
the G
 
i
 
 family of G proteins to mediate chemotaxis but use
other G proteins as well to mediate cytotoxic activities (4,
6). Leukotrienes play a major role in the pathophysiology
of asthma and other pulmonary diseases (7, 8). Several in-
hibitors of leukotriene biosynthesis and activity have been
developed for clinical use (9). Studies on mouse models and
antagonists of LTB
 
4
 
 suggested a role for BLTR in rheuma-
toid arthritis, skin inflammation, and acute septic peritonitis
(10–12). Mice with targeted disruption of 5-lipoxygenase
(5-LO), 5-LO activating protein (FLAP), and, more re-
cently, LTA
 
4
 
 hydrolase allowed the determination of the
role of leukotrienes in inflammation and hypersensitivity
(13–16). Nonenzymatic formation of LTB
 
4
 
 receptor
 
 
 
ago-
nists have been demonstrated (17), and the nuclear receptor
 
peroxisome proliferator-activated receptor 
 
a
 
 was shown to
mediate several of the effects of LTB
 
4
 
 (18). Therefore, to
determine the in vivo biological functions of BLTR and
the potential consequences of chronic BLTR deficiency,
we used gene targeting in embryonic stem (ES) cells to dis-
rupt the mouse 
 
BLTR
 
 gene. The results demonstrate that
BLTR deficiency blocks cellular responses to LTB
 
4 
 
and
diminishes acute inflammatory responses. The data also dis-
closed an unexpected role for BLTR in sex-dependent leu-
kotriene effects in mediating hypersensitivity to platelet-
activating factor (PAF).
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Materials and Methods
 
Targeting Construct and Generation of BLTR-deficient Mice.
 
The
mouse 
 
BLTR
 
 gene was isolated as BAC clones from a genomic
library from 129/SvJ strain from Research Genetics using an EST
clone for mouse BLTR (19, 20). The BAC clones were mapped
by restriction analysis, and a 10-kb BamHI fragment (see Fig. 1
A) was subcloned as two BamHI–SacII fragments into pBlue-
script. The knockout construct was made in a vector (
 
pPNT
 
)
containing both 
 
PGK-neo
 
 and 
 
PGK-tk
 
 cassettes (21). A SpeI
linker was added to the SacII end of the 3
 
9
 
 BamHI–SacII clone.
A 1.5-kb SpeI–KpnI fragment from this clone was subcloned into
XbaI–KpnI sites in pPNT vector in between the neo and 
 
tk
 
 cas-
settes. The 5
 
9
 
 BamHI–XhoI fragment was excised from the
pBluescript clone as a NotI–XhoI fragment and cloned into the
same sites of the 
 
pPNT
 
 already containing the 3
 
9
 
 SacII (SpeI)–
KpnI fragment. The resulting final knockout construct pHB–
BLTR was 13 kb in length. A mock construct prepared by insert-
ing the 3
 
9
 
 4.5-kb SacII–BamHI fragment into the same sites of
 
pPNT
 
 served as a positive control for PCR screening of the ES
cell clones. AK7 (129S4/SvJaeSor) ES cells (10
 
7
 
) were electropo-
rated with 25 
 
m
 
g of NotI-linearized pHB–BLTR DNA. The
transfected cells were grown in DMEM media with 200 
 
m
 
g/ml
G418 and 2 
 
3
 
 10
 
2
 
6
 
 M gancyclovir for 10 d. Surviving clones
(95) were tested for recombination using a neomycin-coding se-
quence primer, tcgcagcgcatcgccttctatcg, and a primer from the 3
 
9
 
end of 
 
BLTR
 
 gene external to the knockout construct, gctgg-
gagtcatcaacaagcactc. Of the 25 positive clones, 15 were ex-
panded, and the genotypes were confirmed by Southern blot
analysis with 10–20 
 
m
 
g of DNA using the 0.9-kb probe (BglII–
BamHI fragment) external to the 3
 
9
 
 end of the knockout con-
struct (see Fig. 1 A). Six undifferentiated clones were individually
microinjected into C57BL/6J blastocysts and transferred into
pseudopregnant C57BL/6 mice. Chimeric mice generated from
two individual cell clones resulted in immediate germline trans-
mission, and the F1 (C57BL/6 and 129 SvJ) offspring were used
to establish the mouse colonies. Genotyping was performed using
Southern blot analysis with the same probe indicated above or
more routinely using a three-primer PCR reaction with the
primers (i) tcacttcgaagactcaggaatgg, (ii) tgcggggcagcgtctgaggctgg,
and (iii) ttccatcagaagctgactctac. All mice were housed in a specific
pathogen–free barrier facility. Mice were 8–12 wk old at the time
of use. All studies and procedures were approved by the Animal
Care and Use Committee of Duke University Medical Center.
 
Zymosan-induced Peritoneal Inflammation.
 
Zymosan (Sigma-
Aldrich) was prepared in PBS to a final concentration of 1 mg/ml
as described (15), and 1.0 ml was injected intraperitoneally. Mice
were killed by CO
 
2
 
 asphyxiation, and a peritoneal lavage was
performed 0, 4, 18, or 72 h after injection, with 9 ml of ice cold
RPMI medium containing 2% FCS and 2 mM EDTA. Total cell
counts were determined with a hemocytometer, 50 
 
m
 
l of lavage
fluid was cytospun and stained with Diff-Quik, and the percent-
ages of macrophages, neutrophils, eosinophils, and lymphocytes
were determined from a count of at least 200 cells. These per-
centages were multiplied by the total cell number to obtain the
number of peritoneal neutrophils and macrophages. In some ex-
periments, levels of LTB
 
4
 
 in peritoneal lavage fluids were mea-
sured using an EIA kit from Cayman Chemicals following the
manufacturer’s protocol.
 
Neutrophil Calcium Mobilization and Chemotaxis.
 
The 4-h zymo-
san-elicited peritoneal lavage cells contained 
 
.
 
80% neutrophils
and were used in functional assays. For calcium mobilization, 3 
 
3
 
10
 
6
 
 cells were washed and loaded with 1.0 
 
m
 
M INDO-1 AM for
30 min at room temperature as previously described (6). Calcium
traces were recorded in a Perkin-Elmer fluorescence spectrome-
ter (model 650-19) with an excitation wavelength of 355 nm and
an emission wavelength of 405 nm. Chemotaxis of peritoneal ex-
udate cells was measured by a 48-well microchemotaxis chamber
technique as described (6).
 
Arachidonic Acid–induced Ear Inflammation.
 
Mice were intrave-
nously injected with PBS containing 0.5% Evans blue and in-
domethacin (Sigma-Aldrich) at final amounts of 10 mg/kg body
weight to minimize the contribution from cyclooxygenase prod-
ucts (14). The inside of the right ear of each mouse was painted
with 20 
 
m
 
l of arachidonic acid (AA; 100 mg/ml in acetone;
Sigma-Aldrich), and the left ear was painted with acetone alone.
Ear thickness was measured at 0 and 90 min after AA application
using a calibrated thickness gauge (Mitutoyo). Mice were killed
by CO
 
2
 
 asphyxiation, a 5-mm-diameter disc of tissue was
punched from the center of each ear, and edema was measured by
determining the wet weight of the ear punches. The punches
were then extracted in 0.5 ml of formamide at 55
 
8
 
C for 48 h.
Evans blue extravasation was determined by measuring the absor-
bance at 610 nm in a spectrophotometer. Histological sections of
the ears were stained with hematoxylin and eosin.
 
PAF-induced Anaphylaxis.
 
Mice were intravenously injected
with PAF-16 (Calbiochem) at a dose of 200 
 
m
 
g/kg body weight
in saline containing 0.25% BSA. Animals were observed over a
24-h period. All animals alive after 1 h made a full recovery.
 
Results
 
Generation of BLTR-deficient Mice.
 
To selectively ablate
BLTR, a targeting vector that deleted the coding region of
BLTR between amino acids 81 and 316 and replaced it
with the PGK–neomycin (
 
PGK-Neo
 
) cassette was con-
structed (Fig. 1 A). After electroporation into ES cells,
screening of 95 individual neomycin- and gancyclovir-
resistant colonies by PCR yielded 25 positive recombinant
targeted clones. A 3
 
9
 
 probe was selected for Southern blot
screening of 15 of these clones, and the results indicated
that they were all correctly targeted (data not shown). Of
the six clones injected into C57BL/6 blastocysts, all yielded
chimeric mice; four of the males succeeded in efficient
germline transmission. All of the animals in this study con-
sisted of offspring derived from the crossings of F1 het-
erozygous mice. Fig. 1 B shows a Southern blot of BamHI-
and XhoI-digested DNA from the three genotypes. The
wild-type littermate lanes (
 
1
 
/
 
1
 
) show the expected 5.2-
kb band, and the homozygous lanes (
 
2
 
/
 
2
 
) show the 6.5-
kb mutant band. The heterozygous (
 
1
 
/
 
2
 
) lanes show both
the wild-type and mutant bands. Mice deficient for BLTR
(BLTR
 
2
 
/
 
2
 
) were born at the expected Mendelian ratios,
showed no overt developmental or morphological abnor-
malities, and were fertile. A three-primer PCR (Fig. 1 C)
was routinely used to determine the genotypes from the
DNA isolated from tail biopsies.
To confirm that the mutation disrupted BLTR expres-
sion and not other chemoattractant receptors, zymosan-
elicited peritoneal exudate cells (
 
.
 
80% neutrophils) were
analyzed for calcium mobilization and chemotaxis. LTB
 
4
 
,
C5a, and PAF all induced calcium mobilization in cells 
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from littermate wild-type animals (Fig. 2 A). In contrast,
cells from the BLTR
 
2
 
/
 
2
 
 animals showed no calcium mo-
bilization in response to LTB
 
4
 
 but showed equivalent
responses to C5a and PAF compared with cells from
BLTR
 
1
 
/
 
1
 
 mice. In addition, no calcium response was ob-
served even at 1.0 
 
m
 
M LTB
 
4
 
 in cells from BLTR
 
2
 
/
 
2
 
 ani-
mals (data not shown). Chemotaxis assays also showed no
response to LTB
 
4
 
 by BLTR
 
2
 
/
 
2
 
 cells, whereas cells from
both BLTR
 
2
 
/
 
2
 
 and BLTR
 
1
 
/
 
1
 
 animals showed similar lev-
els of migration to C5a (Fig. 2 B). Peritoneal injection of
LTB
 
4 led to a rapid neutrophil influx in BLTR1/1 mice
that was completely abrogated in BLTR2/2 mice (Fig. 2 C;
P , 0.05). No statistically significant differences were ob-
served in macrophage numbers at this time point.
Analysis of lymphoid tissues found no gross alterations in
the size of the thymus, spleen, or lymph nodes between
BLTR2/2 and BLTR1/1 littermates. The number and dis-
tribution of CD41 and CD81 T lymphocytes or B2201 B
lymphocytes found within the spleen, peripheral lymph
nodes, mesenteric lymph nodes, or within the blood were
similar in BLTR2/2 and BLTR1/1 animals (data not
shown). In addition, no significant differences were found
in numbers of circulating lymphocytes, monocytes, neutro-
phils, or eosinophils or in serum IgG and IgM levels be-
tween the BLTR2/2 and BLTR1/1 mice (data not shown).
Peritoneal Inflammation Induced by Zymosan. To assess
the role of BLTR in neutrophil and macrophage recruit-
ment in response to a “nonspecific” inflammatory stimulus,
zymosan was injected into the peritoneum of BLTR1/1 and
BLTR2/2 mice. In uninjected mice, there were no signifi-
cant differences in the resident peritoneal leukocyte popula-
tions in the BLTR1/1 versus BLTR2/2 mice (Fig. 3). In
contrast, 4 and 18 h after zymosan injection, significantly
fewer neutrophils were recovered from BLTR2/2 relative to
BLTR1/1 mice (Fig. 3 A; P , 0.05). Likewise, significantly
lower numbers of macrophages were recovered from
BLTR2/2 relative to BLTR1/1 mice at 18 h after injection
(Fig. 3 B; P , 0.01). However, at 72 h after injection, no
differences were seen in the recovery of either cell type from
BLTR2/2 or BLTR1/1 mice. Levels of LTB4 in peritoneal
lavage fluids at 4 h ranged from 1.2 6 0.3 ng/ml in BLTR1/1
animals to 1.0 6 0.2 ng/ml in BLTR2/2 animals.
AA-induced Ear Inflammation. When applied topically,
AA induces an acute inflammatory reaction involving both
vascular leakage and cellular components that is highly de-
pendent on leukotrienes (13–15). To determine which if
Figure 1. Targeted disruption of mouse BLTR. (A) Wild-type ge-
nomic locus of BLTR, targeting vector, and the recombinant mutant ge-
nomic locus. Coding region of the BLTR gene is indicated as a solid box.
706 bp of the coding region between the XhoI and SacII sites was re-
placed with PGK-Neo in the targeting vector. The final construct con-
tained homology arms of 4.0 and 1.5 kb. A BglII–BamHI fragment served
as an external probe for Southern blot analysis of genomic DNA from ES
cells and mouse tails. (B) Southern blot showing correct targeting and
germline transmission of the mutated BLTR gene. Genomic DNA samples
prepared from F2 offspring were digested with BamHI and XhoI, sepa-
rated on 0.6% agarose gels, blotted onto nylon membranes, and hybridized
with the 32P-labeled, 0.9-kb BglII–BamHI fragment. The genotypes of
the mice are indicated above the lanes. (C) A three-primer PCR reaction
was designed to identify the wild-type, heterozygous, and homozygous
mutant alleles. The genotypes of the mice identified by this method con-
firmed the identifications by the Southern blot method in all cases tested.
Figure 2. Loss of BLTR function in neutrophils from BLTR2/2 mice.
(A) Calcium mobilization was monitored in INDO-1–loaded, zymosan-
elicited peritoneal neutrophils stimulated with 100 nM LTB4, 100 nM
C5a, or 100 nM PAF as indicated. Each tracing represents an analysis of 3 3
106 cells from a single mouse with the indicated BLTR genotype, and
the data shown is representative of at least six each of BLTR1/1 and
BLTR2/2 animals. (B) Neutrophil chemotaxis. The chemotactic response
of zymosan-elicited peritoneal neutrophils from a single BLTR1/1 or
BLTR2/2 mouse to LTB4 (100 nM) and C5a (100 nM) was determined
by counting the number of migrated cells within five high-powered fields
(4003) representing three individual wells. Results are representative of
at least four mice for each genotype. Differences in LTB4 responses be-
tween BLTR1/1 and BLTR2/2 mice is statistically significant (*P  ,
0.05). (C) LTB4-induced peritonitis. Six mice of each genotype were in-
jected intraperitoneally with 1.0 ml of saline containing 10 mg of LTB4,
and 4 h later, peritoneal exudate cells were harvested. Values represent
the mean 6 SEM. The difference in neutrophil accumulation between
BLTR1/1 and BLTR2/2 mice is statistically significant (*P , 0.05).436 Leukotriene B4 Receptor–deficient Mice
mals. However, a significant difference was observed in the
survival of BLTR2/2 animals when the results were segre-
gated by sex. As shown in Table I, the female BLTR2/2 an-
imals displayed a selective advantage, with 6 of the 9 animals
surviving PAF treatment, whereas only 1 of 11 male
BLTR2/2 animals survived the treatment. By contrast, the
littermate BLTR1/1 male and female animals did not show
any significant differences in their survival.
Discussion
The deletion of the BLTR gene reported in this study
reveals the critical role this receptor plays in acute inflam-
mation and immediate hypersensitivity. The BLTR2/2
mice were viable, developed and reproduced normally, and
displayed no overt behavioral or morphological defects.
The number and the development of lymphocyte subpop-
ulations was normal in BLTR2/2 mice. Although the
BLTR2/2 mice exhibited no obvious phenotype in a spe-
cific pathogen–free environment, exposure to inflamma-
tory challenges revealed significant defects in neutrophil
and macrophage recruitment and conferred a survival ad-
vantage in females to PAF-induced anaphylaxis.
The lack of developmental defects correlates with the
observation that mice deficient for 5-LO, FLAP, or LTA4
hydrolase all develop normally, indicating that neither en-
zymatic production of leukotrienes nor their action on spe-
cific receptors is essential for growth or development (13–
16). Similarly, no developmental defects have been observed
in mice deficient for C5a or N-formylpeptide receptors, in-
dicating the nonessential nature of individual neutrophil
chemoattractant receptors (22, 23). The observation that
elicited peritoneal neutrophils did not display any calcium
mobilization or chemotaxis to LTB4, and the complete ab-
sence of neutrophil accumulation to peritoneal LTB4 chal-
lenge in the BLTR2/2 mice indicates that BLTR is likely
the sole LTB4-responsive G protein–coupled receptor me-
diating inflammatory responses in mice.
Recent studies demonstrated that transgenic mice overex-
pressing human BLTR displayed a profound increase in neu-
trophil recruitment in skin inflammation, peritonitis, and
reperfusion-initiated second organ injury (24). These results
are in agreement with the current studies that neutrophil in-
flux was reduced at early times (4 and 18 h) in zymosan-
induced peritonitis. In addition, a reduction in the 18-h re-
cruitment of macrophages suggests a role for LTB4 in the
early times of monocyte/macrophage migration during peri-
toneal inflammation. Zymosan activates complement to pro-
duce C5a, resulting in neutrophil influx (25). The data from
the studies in this paper indicate that LTB4 and BLTR also
play a role in this process. Indeed, previous studies indicated
that LTB4 is the major AA metabolite produced by the en-
tering neutrophils in murine zymosan-induced peritonitis
(25). LTB4 likely produced by the resident macrophages
and/or early accumulating neutrophils may be involved in
an autocrine loop of neutrophil accumulation during inflam-
mation. The early reduction of neutrophil influx in BLTR2/2
Figure 3. Peritoneal leukocyte accumulation in BLTR1/1 and
BLTR2/2 mice. (A) Neutrophil and (B) macrophage accumulation after
zymosan injection. The mean number of each leukocyte type (6SEM) in
peritoneal lavage samples isolated at the times indicated after zymosan in-
jection are presented. The number of animals for each time point con-
sisted of five to nine animals. Statistically significant differences are indi-
cated (*P , 0.05 and **P , 0.01).
any of these inflammatory reactions were mediated by
BLTR, the BLTR1/1 and BLTR2/2 animals were treated
with AA and edema, and vascular permeability was mea-
sured by changes in swelling, ear weight, and Evans blue
dye extravasation. BLTR1/1 mice showed significant ear
inflammation 90 min after AA application (Fig. 4). Specifi-
cally, the AA-treated ears showed a 60% increase in weight,
270% increase in leakage of Evans blue, and 63% increase
in thickness (data not shown) compared with vehicle only–
treated ears. In contrast, AA-treated ears from BLTR2/2
animals showed no significant increase in thickness or
weight and only a 118% increase in Evans blue leakage
compared with control ears. Histological examination of
the tissue showed neutrophil infiltration only in BLTR1/1
and not in BLTR2/2 mice (Fig. 4, C and D).
PAF-induced Anaphylaxis. PAF is an important endoge-
nous mediator of systemic anaphylactic shock in mice (13).
Intravenous injection of PAF leads to hypotension, increased
vascular permeability, vasodilation, bronchospasm, and en-
dothelial adhesion and activation of neutrophils, macro-
phages, and eosinophils, resulting in death within an hour.
Previous studies indicated that leukotrienes are important if
not sole mediators of this response (13–16). PAF, when ad-
ministered at a dose of 200 mg/kg body weight, resulted in
the death of 16 of 20 BLTR1/1 animals. This was not signifi-
cantly different from the death of 13 of 20 BLTR2/2 ani-437 Haribabu et al. Brief Definitive Report
mice may have resulted in reduced synthesis of other media-
tors for further monocyte influx. However, the similar mac-
rophage levels at 72 h after zymosan treatment in the
BLTR2/2 and BLTR1/1 mice indicate the existence of as
yet unknown compensatory mechanisms.
Previous studies with mice deficient in leukotriene syn-
thesis showed decreased inflammatory responses to AA
(14–16). Although the relative contributions of LTB4 and
LTC4 were not clear, both protein extravasation and cellu-
lar infiltration were affected. Intermediate responses were
observed in LTA4 hydrolase–deficient mice relative to
5-LO– and FLAP-deficient mice. However, the LTA4 hy-
drolase–deficient mice produced larger amounts of LTC4
relative to control mice. Current studies with BLTR2/2
mice indicate that both edema and cellular components of
inflammation were decreased, suggesting a role for BLTR
in both vascular leakage and neutrophil accumulation.
A surprising observation from the current studies in this
paper is the relative resistance of female BLTR2/2 mice to
PAF-induced immediate hypersensitivity. Previous studies
with 5-LO– and FLAP-deficient animals showed a strong
protection from PAF-induced lethality (13–15). However,
sex differences in survival, if any, were not reported. These
studies show clear differences in the survival of female ver-
sus male BLTR2/2 mice to challenge with PAF. Several
autoimmune diseases such as rheumatoid arthritis and sys-
temic lupus erythematosus (SLE) display sex-dependent
predilection, with females being most severely affected (26,
27). In autoimmune disease–prone MRL-lpr/lpr mice, fe-
males are more susceptible to SLE-like pathology, whereas
males appear to express increased inflammatory responsive-
ness to leukotrienes (28). Studies with 5-LO–deficient mice
on the MRL-lpr/lpr background showed that males lost
their survival advantage and became as susceptible to dis-
ease as females, suggesting that leukotrienes protect against
SLE-like disease (28). The relevance, if any, of the sex-
related difference in PAF anaphylaxis in BLTR2/2 mice to
autoimmune diseases is unknown at this time. The loss of
male advantage against SLE in 5-LO–deficient MRL-lpr/lpr
mice needs to be placed in context with our results of gain
of a female advantage in BLTR2/2 mice. We postulate that
a threshold level of leukotriene responsiveness provides
protection against autoimmune disease but produces sus-
ceptibility to PAF-mediated anaphylaxis. If so, males may
have greater leukotriene responsiveness than females. The
mice with 5-LO or BLTR deficiency cross these thresholds
to result in either male susceptibility to SLE or female pro-
tection to PAF anaphylaxis, respectively. Clearly, PAF-
induced anaphylaxis is a complex process, as all 5-LO–defi-
cient mice are protected but the male BLTR2/2 mice are
not. Further studies on hormonal effects will likely delin-
eate the sex-dependent leukotriene effects in these mice.
Table I. Sex-related Differences in PAF-induced Anaphylaxis
Genotype: BLTR1/1 BLTR2/2
Sex Male Female Male Female
Survivors/total 3/11 1/9 1/11 6/9
Mice were injected intravenously with PAF at a dose of 200 mg/kg
body weight and observed for 24 h. The total number of animals tested
for each genotype and sex is shown separately with the number of
surviving animals. The difference in mortality between female and male
BLTR2/2 mice is statistically significant (P = 0.002, Fisher’s exact test).
Figure 4. AA-induced ear inflammation. AA
(2 mg) was applied to the mouse ears and ana-
lyzed for edema and protein extravasation after
90 min as described in Materials and Methods.
(A) Edema: wet weight of a 5-mm ear punch of
the control (white bars) and AA-treated ears
(black bars) was measured. (B) Extravasation:
Evans blue dye leakage was measured at a wave-
length of 610 nm (OD 610): open bar, control
ears; closed bars, AA-treated ears. The decreased
inflammatory response in the AA-treated ears of
BLTR2/2 mice compared with BLTR1/1 mice
was statistically significant (*P , 0.05) for data
in A and B. (C and D) Histology: hematoxylin
and eosin–stained tissue sections from BLTR1/1
(C) and BLTR2/2 (D) mice treated with AA
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In summary, this study has shown that deletion of BLTR
reduced the vascular and cellular components of acute in-
flammatory responses in mice. In addition, these data sug-
gest a role for BLTR in mediating systemic anaphylaxis,
with female mice being more dependent on this pathway
than males. Inhibition of BLTR function may provide a
target for therapeutic intervention in certain human inflam-
matory conditions. Further studies with expression of the
BLTR deficiency on different strain backgrounds will allow
investigation of the role of BLTR in asthma, rheumatoid
arthritis, lupus, and colitis as well as infectious diseases.
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